Jonathon Angell - 23 Jul 2025 Form 3 Insider Report for Deep Isolation Nuclear, Inc.

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
21 Nov 2025, 14:47:33 UTC
Next SEC filing
03 Oct 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jonathon Angell

Key filing fact

Jonathon Angell filed Form 3 for Deep Isolation Nuclear, Inc. on 21 Nov 2025.

Key facts

  • This page summarizes Jonathon Angell's Form 3 filing for Deep Isolation Nuclear, Inc..
  • 0 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 21 Nov 2025, 14:47.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002080569 Primary reporting owner

Angell Jonathon

Relationship
Director
Address
C/O DEEP ISOLATION NUCLEAR, INC., 2001 ADDISON STREET, SUITE 300, BERKELEY
Signature
/s/ Jonathon Angell
Signature date
21 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

No ticker holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
345,574
Date
23 Jul 2025
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

No ticker holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
23 Jul 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
16,148
Exercise price
$0.2000
Footnotes
F2, F3
No ticker holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
23 Jul 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
25,837
Exercise price
$0.1800
Footnotes
F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Received in connection with the Issuer's merger (the "Merger") with Deep Isolation, Inc. ("Deep Isolation") in accordance with the terms of the Agreement and Plan of Merger and Reorganization dated as of July 23, 2025, by and among the Issuer (f/k/a Aspen-1 Acquisition Inc.), Deep Isolation Acquisition Corp. and Deep Isolation (the "Merger Agreement"), in exchange for 13,375 shares of Deep Isolation common stock held by the Reporting Person immediately prior to the effective time of the Merger. Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of Deep Isolation capital stock was converted into the right to receive 25.837283 shares of the Issuer's common stock (the "Conversion Ratio"), rounded to the nearest whole share. The Merger closed on July 23, 2025.

Footnote F2

In connection with the Merger and effective as of immediately prior to the effective time of the Merger, Deep Isolation's Board of Directors approved the accelerated vesting of all outstanding and unexercised stock options previously issued under Deep Isolation's 2018 Equity Incentive Plan (the "2018 EIP"), including the stock options reported herein. Prior to such acceleration, the stock option was subject to a 4-year vesting schedule, whereby 25% of the option shares vested as of March 15, 2023 and 1/48th of the remaining shares were scheduled to vest monthly over the 36-month period thereafter, subject to the Reporting Person's continued service through each vesting date.

Footnote F3

Received in connection with the Merger in accordance with the terms of the Merger Agreement, in exchange for Outstanding Options to acquire 625 shares of Deep Isolation common stock at an exercise price of $5.20 per share held by the Reporting Person immediately prior to the effective time of the Merger. Pursuant to terms of the Merger Agreement, at the effective time of the Merger, the number of shares of Deep Isolation common stock subject to each outstanding but unexercised option to purchase Deep Isolation common stock (each such option, an "Outstanding Option," and such number of shares of Deep Isolation common stock subject to such Outstanding Option, the "option shares") was converted into an option to purchase the number of shares of the Issuer's common stock equal to the option shares multiplied by the Conversion Ratio, rounded to the nearest whole share, and the exercise price of each Outstanding Option was divided by the Conversion Ratio, rounded to the nearest whole cent.

Footnote F4

In connection with the Merger and effective as of immediately prior to the effective time of the Merger, Deep Isolation's Board of Directors approved the accelerated vesting of all outstanding and unexercised stock options previously issued under Deep Isolation's 2018 EIP, including the stock options reported herein. Prior to such acceleration, the stock option was subject to a 4-year vesting schedule, whereby 25% of the option shares vested as of June 1, 2024 and 1/48th of the remaining shares were scheduled to vest monthly over the 36-month period thereafter, subject to the Reporting Person's continued service through each vesting date.

Footnote F5

Received in connection with the Merger in accordance with the terms of the Merger Agreement in exchange for Outstanding Options to acquire 1,000 shares of Deep Isolation common stock at an exercise price of $4.61 per share held by the Reporting Person immediately prior to the effective time of the Merger. Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, the number of option shares subject to each Outstanding Option was converted into an option to purchase the number of shares of the Issuer's common stock equal to the option shares multiplied by the Conversion Ratio, rounded to the nearest whole share, and the exercise price of each Outstanding Option was divided by the Conversion Ratio, rounded to the nearest whole cent. The Merger closed on the Merger Closing Date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .